PATENT CLAIM ANALYSIS

Application Number: 16424324
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["424", "181100"]

Abstract:
The present disclosure provides antibody drug conjugates that bind human cMET, their methods of making, and their uses to treat patients having cancer.

Claim (Index 152):
The pharmaceutical composition of  claim 150  having a drug antibody ratio (\u201cDAR\u201d) of about 3.1.

Metadata:
- Claim Count in Document: 67.0
- Percentile: 100.0
- Lexical Diversity: 1.08333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15910788', '15363715', '15363786', '15819153', '14928738']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7299795344300002
- 35 USC 102 Novelty (BERT): 0.601036435249942
- Combined Prediction Score: 0.7170852245119944
- Mean Citation Score: 369.40474200000006
- Max Citation Score: 555.21185
- Similarity Product: 429.0244144004226

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test